headquarters durham north carolina united states key people james c. mullen ceo ; stuart grant cfo and executive vp 1 revenue 1.7 billion 2015 2 number of employees 8 000 3 website www.patheon.com patheon inc. is a pharmaceutical company with its corporate head offices in durham north carolina that provides contract development and manufacturing services of prescription and over the counter pharmaceutical products for approximately 400 pharmaceutical and biotechnology companies . 3 it was founded in 1974 as custom pharmaceuticals ltd. and changed its name to patheon in 1993 when it was first publicly traded . 4 the new york private equity firm jll partners has owned a controlling stake in patheon since 2009 . 5 in 2014 patheon merged with the drug manufacturing business of royal dsm nv becoming a joint venture between jll partners and dsm . 6 as of 2016 patheon owns manufacturing sites in north america europe japan australia . 7 and canada contents 1 history 2 dosage forms products 3 references 4 external links history edit patheon was founded in canada in 1974 as custom pharmaceuticals ltd. in 1990 it began to expand to us markets . custom pharmaceuticals changed its name to patheon in 1993 and was first publicly traded that year on the toronto stock exchange . 4 in 2004 patheon acquired mova a drug manufacturer based in puerto rico us . the deal proved unprofitable and in 2007 the new york equity firm jll partners provided patheon 150 million to restructure . two years later after a failed takeover bid by lonza group jll partners bought a controlling interest in the company . 5 8 in 2013 patheon acquired banner pharmacaps a drug manufacturer specializing in softgels for 255 million . patheon changed the company s name the following year to banner life sciences . 9 in a 2.6 billion deal patheon merged with the pharmaceutical division of royal dsm nv in 2014 after jll partners bought a controlling stake in the latter as well adding significantly to patheon s european production capacity . 6 later that year patheon bought gallus pharmaceuticals acquiring mammalian cell culture lab sites in new jersey us and missouri us . 10 in 2015 patheon acquired agere pharmaceuticals an oregon us company specializing in drug solubility and irix a maker of specialist active pharmaceutical ingredients in south carolina us the latter for 162.78 million . 11 12 patheon won contract manufacturing organization leadership awards from life science leader in 2012 2013 2015 and 2016 . 13 dosage forms products edit patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging with the product licence holder s brand name product name and corporate identity being used . patheon s clients include such pharmaceutical brands as merck & co novartis and sanofi aventis with biotechnology customers including amgen and avanir pharmaceuticals . patheon has manufactured or developed more than 800 products . 14 development activities are undertaken by patheon pharmaceutical development services known as pds a division of patheon inc. operating in europe canada and the united states . as of 2016 patheon owns manufacturing sites in canada the continental us puerto rico france the united kingdom italy austria germany the netherlands japan and australia . 7 patheon manufactures products in various dosage forms oral tablets capsules injectable sterile products vials ampoules pre filled syringes containing liquids powders and lyophilisates and topicals creams ointments drops nasal sprays medicated and non medicated gauze . references edit leadership . patheon.com . patheon . retrieved may 18 2016 . palmer eric june 9 2015 . updated patheon revenues hit 1.7 b in first year as part of dpx . fiercepharma.com . fierce pharma . retrieved may 18 2016 . a b company profile . patheon.com . patheon . retrieved may 18 2016 . a b history and milestones . patheon.com . patheon . retrieved may 18 2016 . a b erman boyd july 29 2009 . long takeover battle a bitter pill for patheon . theglobeandmail.com . the globe and mail . retrieved may 18 2016 . a b xu jodi november 19 2013 . jll forms new pharma firm with dsm in 2.6 billion deal . bloomberg.com . bloomberg . retrieved may 18 2016 . a b sites . patheon.com . patheon . retrieved may 18 2016 . hodson peter december 13 2013 . 5 takeover failures revisited . financialpost.com . financial post . retrieved may 18 2016 . evans matt july 1 2013 . patheon changing banner pharmacaps name . bizjournals.com . triad business journal . retrieved may 18 2016 . stanton dan august 27 2014 . patheon propels itself into us biologics market in gallus acquisition . biopharma reporter.com . biopharma reporter.com . retrieved may 18 2016 . ruckin claire march 9 2015 . trlpc patheon to raise 150 mln euro loan for irix acquisition . reuters.com . reuters . retrieved may 18 2016 . debruyn jason march 11 2015 . oregon pharma company sold to north carolina manufacturer . bizjournals.com . portland business journal . retrieved may 18 2016 . cmo leadership awards . cmoleadershipawards.com . life science leader . 2016 . retrieved may 20 2016 . patheon by the numbers pdf . patheon.com . patheon . retrieved may 18 2016 . external links edit patheon home page retrieved from https en.wikipedia.org w index.php title patheon & oldid 743227278 categories companies established in 1974pharmaceutical companies of canadacompanies based in burlington ontariocompanies listed on the new york stock exchange navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages fran ais edit links this page was last modified on 8 october 2016 at 16 42 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view